PD-1 inhibitors combined with induction chemotherapy followed by chemoradiotherapy in HPV-negative locally advanced head and neck squamous cell carcinoma: a real-world study
Cancer Immunology, Immunotherapy · 25.02.2026 · 75 (3)
DOI: 10.1007/s00262-025-04296-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 25.02.2026. Verfasst von Yi Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Cen…. Hauptthemen laut MEDLINE: Induction Chemotherapy, Chemoradiotherapy, Squamous Cell Carcinoma of Head and Neck, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Project of Guangzhou Science and Technology Plan, National Natural Science Foundation of China, the Sun Yat-Sen University Clinical Research 5010 Program.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: To compare the efficacy of induction chemotherapy with or without PD-1 inhibitors followed by chemoradiotherapy (CCRT) among patients with human papillomavirus (HPV)-negative locally advanced head and neck squamous cell carcinoma (LA-HNSCC). MATERIALS AND METHODS: We retrospectively reviewed patients with HPV-negative LA-HNSCC who received induction chemotherapy with or without PD-1 inhibitors followed by CCRT between January 2018 and June 2023. Overall survival (OS), disease-free survival (DFS), and treatment-related adverse effects (TRAEs) were compared between the two groups overall and then in one-to-one propensity-score matched (PSM) cohorts. RESULTS: A total of 289 eligible patients were enrolled, with 120 patients received induction chemotherapy (the IC group), and 169 patients received induction chemotherapy combined with PD-1 inhibitors (the IC-IO group). Median follow-up was 39.3 months (range: 37.5-41.5 months). After PSM, objective response rate (ORR) was not significantly different in the IC-IO group versus the IC group (81.5% vs 74.1%, P = 0.19). The IC-IO group (vs. the IC group) had a superior 2-year OS (84.3% vs. 68.2%, P = 0.002) and DFS (74.1% vs. 56.9%, P = 0.005). G3/4 TRAEs between the two matched groups were comparable both during induction (11.1% vs 11.1%, P = 1.000) or CCRT (29.6% vs 38.9%, P = 0.152) phases. For the IC-IO group, no significant differences in OS (P = 0.68) or DFS (P = 0.29) were observed in the subset with versus without PD-1 inhibitors concurrently with CCRT. CONCLUSIONS: The addition of PD-1 inhibitors to IC significantly improves outcomes with tolerable TRAEs in patients with HPV-negative LA-HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Ca…
- Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guang…
- Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. Shaohui.Huang@uhn.ca.
Förderung
- Basic and Applied Basic Research Project of Guangzhou Science and Technology Plan
- National Natural Science Foundation of China
- the Sun Yat-Sen University Clinical Research 5010 Program
Zitieren
APA
Yang, Y., Wang, S., Peng, S., Li, Y., Lei, Y., Zheng, W., Xu, S., Huang, S., Huang, Y., & Mao, Y. (2026). PD-1 inhibitors combined with induction chemotherapy followed by chemoradiotherapy in HPV-negative locally advanced head and neck squamous cell carcinoma: a real-world study. Cancer Immunology, Immunotherapy, 75(3). https://doi.org/10.1007/s00262-025-04296-6
Vancouver
Yang Y, Wang S, Peng S, Li Y, Lei Y, Zheng W, et al. PD-1 inhibitors combined with induction chemotherapy followed by chemoradiotherapy in HPV-negative locally advanced head and neck squamous cell carcinoma: a real-world study. Cancer Immunology, Immunotherapy. 2026;75(3). doi:10.1007/s00262-025-04296-6
BibTeX
@article{Yang2026,
author = {Yang, Yi and Wang, Shunxin and Peng, Shuzhen and Li, Yu and Lei, Yiming and Zheng, Weihong and Xu, Sha and Huang, Shaohui and Huang, Ying and Mao, Yanping},
title = {PD-1 inhibitors combined with induction chemotherapy followed by chemoradiotherapy in HPV-negative locally advanced head and neck squamous cell carcinoma: a real-world study},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
volume = {75},
number = {3},
doi = {10.1007/s00262-025-04296-6}
}
EUVIMED